These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1851859)

  • 1. Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons.
    Choi WS; Pal-Ghosh R; Morrow CD
    J Virol; 1991 Jun; 65(6):2875-83. PubMed ID: 1851859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection.
    Porter DC; Ansardi DC; Choi WS; Morrow CD
    J Virol; 1993 Jul; 67(7):3712-9. PubMed ID: 8389902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells.
    Pal-Ghosh R; Morrow CD
    J Virol; 1993 Aug; 67(8):4621-9. PubMed ID: 8392603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans.
    Porter DC; Ansardi DC; Morrow CD
    J Virol; 1995 Mar; 69(3):1548-55. PubMed ID: 7853488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies.
    Luo L; Li Y; Cannon PM; Kim S; Kang CY
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10527-31. PubMed ID: 1438241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the expression and immunogenicity of poliovirus replicons that encode simian immunodeficiency virus SIVmac239 Gag or envelope SU proteins.
    Anderson MJ; Porter DC; Moldoveanu Z; Fletcher TM; McPherson S; Morrow CD
    AIDS Res Hum Retroviruses; 1997 Jan; 13(1):53-62. PubMed ID: 8989427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
    Ding SF; Lombardi R; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins.
    Moldoveanu Z; Porter DC; Lu A; McPherson S; Morrow CD
    Vaccine; 1995 Aug; 13(11):1013-22. PubMed ID: 8525684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production.
    Park J; Morrow CD
    J Virol; 1991 Sep; 65(9):5111-7. PubMed ID: 1870215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of foreign proteins by poliovirus polyprotein fusion: analysis of genetic stability reveals rapid deletions and formation of cardioviruslike open reading frames.
    Mueller S; Wimmer E
    J Virol; 1998 Jan; 72(1):20-31. PubMed ID: 9420196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poliovirus replicons that express the gag or the envelope surface protein of simian immunodeficiency virus SIV(smm) PBj14.
    Anderson MJ; Porter DC; Fultz PN; Morrow CD
    Virology; 1996 May; 219(1):140-9. PubMed ID: 8623523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase.
    Ansardi DC; Pal-Ghosh R; Porter D; Morrow CD
    J Virol; 1995 Feb; 69(2):1359-66. PubMed ID: 7815522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherent instability of poliovirus genomes containing two internal ribosome entry site (IRES) elements supports a role for the IRES in encapsidation.
    Johansen LK; Morrow CD
    J Virol; 2000 Sep; 74(18):8335-42. PubMed ID: 10954532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirements for RNA replication of a poliovirus replicon by coxsackievirus B3 RNA polymerase.
    Bell YC; Semler BL; Ehrenfeld E
    J Virol; 1999 Nov; 73(11):9413-21. PubMed ID: 10516050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budding and secretion of HIV Gag-Env virus-like particles from recombinant human adenovirus infected cells.
    Luo L; Li Y; Yong Kang C
    Virus Res; 2003 Mar; 92(1):75-82. PubMed ID: 12606078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 replication.
    Freed EO
    Somat Cell Mol Genet; 2001 Nov; 26(1-6):13-33. PubMed ID: 12465460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.
    Porter DC; Melsen LR; Compans RW; Morrow CD
    J Virol; 1996 Apr; 70(4):2643-9. PubMed ID: 8642700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1993 Jun; 67(6):3684-90. PubMed ID: 8388519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J; Morrow CD
    Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.